Before I head to a new assignment, here are some final words on a few topics.
https://www.nytimes.com/2015/11/03/opinion/and-thats-my-opinion.html
Allegations about Valeant’s practices and its own disclosures while under pressure cause one to wonder.
https://www.nytimes.com/2015/10/27/opinion/is-valeant-pharmaceuticals-the-next-enron.html
Legislative “reform” is hurting legitimate inventors.
https://www.nytimes.com/2015/10/24/opinion/the-patent-troll-smokescreen.html
Jonathan Mahler’s piece on the Osama bin Laden raid is as much about the nature of journalism as it is about the facts surrounding the event.
https://www.nytimes.com/2015/10/20/opinion/osama-bin-ladens-first-draft.html
Of course they can. So why won’t anti-tobacco advocates get behind them?
https://www.nytimes.com/2015/10/17/opinion/can-e-cigarettes-save-lives.html
The screenwriter says his new movie is not a biopic. So true. The film simply doesn’t understand its subject.
https://www.nytimes.com/2015/10/13/opinion/aaron-sorkins-steve-jobs-con.html
When it comes to government handouts, the conservative billionaires don’t necessarily practice what they preach.
https://www.nytimes.com/2015/10/11/opinion/sunday/corporate-welfare-for-the-kochs.html
A chemical-safety bill in the Senate shows the wisdom of “good, old-fashioned legislating.”
https://www.nytimes.com/2015/10/06/opinion/the-case-for-compromise.html
The association is happy with a ruling that found it violated the law.
https://www.nytimes.com/2015/10/03/opinion/joe-nocera-obannons-hollow-victory.html
He says yes. His positions on the issues suggest otherwise.
https://www.nytimes.com/2015/09/29/opinion/joe-nocera-is-donald-trump-serious.html